Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab

Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab

US Patent 11071780 · Granted Jul 27, 2021

Estimated economic value: $388,896,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activin a antibody formulations and methods of use thereof2025
Devices and methods for overfilling drug containers2025
Devices and methods for overfilling drug containers2025
Methods for predicting and modulating glycation of a protein2025
VEGF antagonist formulations suitable for intravitreal administration2025
VEGF antagonist formulations suitable for intravitreal administration2025
Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative2025
Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative2025
Methods for treating angiogenic eye disorders with high doses of VEGF receptor f2024
Methods for treating angiogenic eye disorders with high doses of VEGF receptor f2024
Non-human animals models of retinoschisis2024
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodie2024